AARTI DRUGS share price has zoomed 7% and is presently trading at Rs 573.2.
Meanwhile, the BSE HEALTHCARE index is at 42,010.1 .
Among the top gainers in the BSE HEALTHCARE index today are HIKAL CHEMIC (up 3.6%) and AJANTA PHARMA (up 2.8%).
Procter & Gamble Health (down 3.0%) and GSK Pharma (down 2.1%) are among the top losers today.
Over the last one year, AARTI DRUGS has moved up from Rs 558.1 to Rs 573.2, registering a gain of Rs 15.1 (up 2.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 42,010.1, registering a gain of 49.9% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 131.0%), Glenmark Pharma (up 115.1%) and GSK Pharma (up 113.6%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 80,995.3 (up 0.1%).
The top gainers among the BSE Sensex today are Bharti Airtel (up 1.2%) and Asian Paints (up 0.7%). The most traded stocks in the BSE Sensex are Bharti Airtel and Tata Steel.
In the meantime, NSE Nifty is at 24,799.8 (up 0.1%). Grasim Industries and Tata Consumer Products are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 80,995.3, registering a gain of 15,779.2 points (up 24.2%).
AARTI DRUGS net profit fell 30.6% YoY to Rs 333 million for the quarter ended June 2024, compared to a profit of Rs 480 million a year ago. Net sales declined 16.0% to Rs 5,553 million during the period as against Rs 6,611 million in April-June 2023.
For the year ended March 2023, AARTI DRUGS reported 18.8% decrease in net profit to Rs 1,664 million compared to net profit of Rs 2,050 million during FY22. Revenue of the company grew 9.1% to Rs 27,161 million during FY23.
The current Price to earnings ratio of AARTI DRUGS, based on rolling 12 month earnings, stands at 33.6.
Equitymaster requests your view! Post a comment on "AARTI DRUGS Gains 7%; BSE HEALTHCARE Index Up 0.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!